Toggle navigation
TWunroll
TWunroll
faq
Contact US
Matthew J. Maurer
MaurerStats
Some #ASH20 DLBCL thoughts and observations. I feel like we are at the tip of a changing landscape for therapy and trial design in DLBCL, both newly dx and R/R.
Read more
Looking forward to moderating oral presentations on biomarkers and prognostication in aggressive #lymphoma with @SoniSmithMD on Monday morning. We have some exciting #ASH20 abstracts to discuss. https://ash.confex.com/ash/2020/webprogram/Se
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree